Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2008
11/19/2008CN101307317A Method for preparing rabies virus antigen
11/19/2008CN101307312A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
11/19/2008CN101307306A Target point protein for screening antitubercular agent
11/19/2008CN101307305A Low virulent strain of porcine reproductive and respiratory syndrome virus, immunogenicity immunogenicity material and vaccine
11/19/2008CN101307098A Preparation method of enhancing peptide fragment immunocompetence and use
11/19/2008CN101307097A Preparation method of enhancing peptide fragment immunocompetence and use
11/19/2008CN101307096A Preparation method of enhancing peptide fragment immunocompetence and use
11/19/2008CN101307076A Prodrug with liver-targeted anti-HBV effect
11/19/2008CN101307064A Process for preparing cefquinome sulfate
11/19/2008CN101307063A Novel cephalosporin compounds, preparation method thereof, pharmaceutical compositions thereof and use
11/19/2008CN101307060A Process for preparing hemihydrate of levofloxacin
11/19/2008CN101307050A Oxazole substituted dihydro pyrazol multi-heterocyclic ring derivates, preparation method and uses thereof
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/19/2008CN101306200A Preparation method of hepatitis b human immunoglobulin for intravenous injection
11/19/2008CN101306199A Method for producing and purifying hepatitis a inactivated vaccine
11/19/2008CN101306186A Traditional Chinese medicine taken orally for treating Qi stagnation and blood stasis type zoster
11/19/2008CN101306164A Chinese herbal medicine for treating livestock foot-and-mouth disease
11/19/2008CN101306144A Decoction for treating otitis media suppurativa acuta
11/19/2008CN101306137A Decoction for treating of herpes zoster of dampness and heat in the live and the gallbladder type
11/19/2008CN101306135A Avian influenza prevention powder
11/19/2008CN101306133A Oral liquid for anti-AIDS
11/19/2008CN101306130A Sanjialongdan Ruangan pill
11/19/2008CN101306128A Decoction for treating otitis media suppurativa acuta
11/19/2008CN101306126A Quality control method of compound south isatis root granules
11/19/2008CN101306125A Decoction for treating acute conjunctivitis
11/19/2008CN101306121A Steaming and washing medicament for treating acute conjunctivitis
11/19/2008CN101306110A Veterinary herbal medicine for preventing and treating hog cholera
11/19/2008CN101306102A Ear drops for treating otitis media suppurativa acuta
11/19/2008CN101306095A Chinese medicinal materials orally taken for treating recurrent genital herpes
11/19/2008CN101306085A External drug for treating tinea on manus and pedes of squamus and vesiclar type
11/19/2008CN101306084A Clove iridoid glycoside extraction separation technique
11/19/2008CN101306080A Elsholtzia spray
11/19/2008CN101306079A Decoction for treating poliomyelitis
11/19/2008CN101306078A Preparation method of duckling liver protection decoction
11/19/2008CN101305780A Multi-flavor long-acting noodles for preventing and treating cold and its production method
11/19/2008CN100434510C Novel galactooligosaccharide composition and the preparation thereof
11/19/2008CN100434441C Inhibition of viral infection using monovalent antigen-binding proteins
11/19/2008CN100434119C Method for producing yelk antibody liquid in high immunity
11/19/2008CN100434083C Medicinal use of fugu cod liver oil
11/19/2008CN100434079C Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
11/19/2008CN100434078C Ambroxol hydrochloride compound slow-release tablet and its preparing method
11/19/2008CN100434076C Compounding prepn. contg. cefteram pivoxil and pidotimod
11/19/2008CN100434075C Usage of caffeine and its analogue in resistance of hepatitis B replication and use thereof in preparation of medicament for treating viral hepatitis
11/19/2008CN100434074C Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating skin mucosa herpes viral infection
11/19/2008CN100434073C Use of chloride 13-hexyl berberine in preparation of medicine for treating peptic ulcer and bacteriological gastroenteritis
11/19/2008CN100434067C Medicine for treating chickens and pigs infected by mixed mycoplasma and other bacteria
11/18/2008US7452999 Chemical process for the preparation of intermediates to obtain N-formyl hydroxy-lamine compounds
11/18/2008US7452992 Heterocyclic compounds as CCR5 antagonists
11/18/2008US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα
11/18/2008US7452963 From 7 to 50 amino acids comprising: (1) a lysine residue six to ten residues from a second lysine residue; (2) a histidine residue; and (3) at least 6% lysine residues
11/18/2008US7452900 Esters in position 20 of camptothecins
11/18/2008US7452898 Use of 1-O-octadecylpropanediol-3-cidofovir to treat viral diseases such as HIV, influenza, herpes virus, cytomegalovirus, hepatitis virus, Epstein-Barr virus, varicella zoster virus, orthopox virus, ebola virus and papilloma virus
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452876 8-Cyclohexyl-1,1a,2,12b-tetrahydro-1a-(4-morpholinylcarbonyl)-cycloprop[d]indolo[2,1-a][2]benzazepine-5-carboxylic acid, methyl ester; RNA polymerase, HCV metalloprotease, HCV serine protease, HCV polymerase, HCV helicase inhibitor; liver disease, including cirrhosis and hepatocellular carcinoma
11/18/2008US7452873 Inhibitors of GSK-3 and uses thereof
11/18/2008US7452861 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452723 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
11/18/2008US7452715 expression of the lipidated form of the peptidoglycan-associated protein (PAL) of gram-negative bacteria is achieved through the use of a plasmid containing a tightly regulated promoter; bacterial host cell transformed, transduced or transfected with the plasmid
11/18/2008US7452535 Methods of treatment using CTLA-4 antibodies
11/18/2008US7452533 Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol
11/18/2008US7452530 Administering a blocking agent of tumor necrosis factors or receptors; treatment of Sin Nombre (SNV), Ebola, Marburg, Lassa, and Dengue viral disease
11/18/2008CA2632032A1 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly
11/18/2008CA2462572C Tetracycline derivatives and methods of use thereof
11/18/2008CA2440222C Triazolopyridines as anti-inflammatory agents
11/18/2008CA2423659C Antiviral composition and treatment method
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2413163C 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
11/18/2008CA2343284C Topical application products
11/18/2008CA2341366C Micronised pharmaceutical compositions
11/18/2008CA2340912C Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
11/18/2008CA2331187C Water soluble azoles as broad-spectrum antifungals
11/18/2008CA2321658C Disinfecting composition
11/18/2008CA2314564C Phosphonocephem derivatives, their production and use
11/18/2008CA2301646C Pharmaceutical suspension comprising nevirapine hemihydrate
11/18/2008CA2298057C Nucleotide analog compositions
11/18/2008CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/18/2008CA2259430C Water miscible erythromycin solutions
11/18/2008CA2157975C Recombinant mersacidin and a method for production
11/18/2008CA2156495C Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells
11/18/2008CA2136230C Clostridium perfringens vaccines
11/18/2008CA2124161C Pharmaceuticals for treating sepsis and septic shock
11/18/2008CA1341585C Recombinant retroviruses
11/18/2008CA1341583C Interferons and process for their preparation
11/14/2008CA2685748A1 Azido purine nucleosides for treatment of viral infections
11/13/2008WO2008137779A2 Novel macrocyclic inhibitors of hepatitis c virus replication
11/13/2008WO2008137128A2 Methods of treating fungal infections
11/13/2008WO2008137126A2 Combination therapy for the treatment of hcv infection
11/13/2008WO2008136867A2 Chlamydia pneumoniae vaccine and methods for administering such a vaccine
11/13/2008WO2008136856A2 Resorbable pouches for implantable medical devices
11/13/2008WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008WO2008136324A1 Pyridine derivative substituted with heterocycle and phosphonoamino and antifungal agent containing the same
11/13/2008WO2008135661A2 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008WO2008135514A1 Vaccine
11/13/2008WO2008135446A2 Klebsiella antigens
11/13/2008WO2008135237A1 Complement factor h-derived short consensus repeat-antibody constructs
11/13/2008WO2008134934A1 A truncated l1 protein of human papillomavirus 16
11/13/2008WO2008134882A1 Methods and compositions for use of cyclic analogues of histatin
11/13/2008WO2008111020A3 Macrolide derivatives as antibacterial agents
11/13/2008WO2008109837A3 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
1 ... 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 ... 1798